As dysfunction in the MRN functionality leads to hypersensitivity to DNA-damage agents by impairment of ATM pathway, inhibiting one of the MRN complex components represents an attractive strategy to induce cancer cell death in combination with DNA-damaging treatment. The gene discussed is ATM; the disease is cancer.